Skip to main content

Published locations for Docetaxel Bests Erlotinib in EGFR Wild-Type Lung Cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Docetaxel Bests Erlotinib in EGFR Wild-Type Lung Cancer

User login

  • Reset your password
  • /content/docetaxel-bests-erlotinib-egfr-wild-type-lung-cancer
  • /familypracticenews/article/54945/lung-cancer/docetaxel-bests-erlotinib-egfr-wild-type-lung-cancer
  • /internalmedicinenews/article/54945/lung-cancer/docetaxel-bests-erlotinib-egfr-wild-type-lung-cancer
  • /pulmonary-health-hub/article/54945/lung-cancer/docetaxel-bests-erlotinib-egfr-wild-type-lung-cancer
  • /oncologypractice/article/54945/lung-cancer/docetaxel-bests-erlotinib-egfr-wild-type-lung-cancer
  • /hematology-oncology/article/54945/lung-cancer/docetaxel-bests-erlotinib-egfr-wild-type-lung-cancer
  • /internalmedicine/article/54945/lung-cancer/docetaxel-bests-erlotinib-egfr-wild-type-lung-cancer
  • /familymedicine/article/54945/lung-cancer/docetaxel-bests-erlotinib-egfr-wild-type-lung-cancer